India Glycols Balance Sheet Health
Financial Health criteria checks 3/6
India Glycols has a total shareholder equity of ₹21.4B and total debt of ₹16.3B, which brings its debt-to-equity ratio to 76.4%. Its total assets and total liabilities are ₹55.5B and ₹34.2B respectively. India Glycols's EBIT is ₹3.6B making its interest coverage ratio 3.6. It has cash and short-term investments of ₹1.0B.
Key information
76.4%
Debt to equity ratio
₹16.31b
Debt
Interest coverage ratio | 3.6x |
Cash | ₹1.03b |
Equity | ₹21.36b |
Total liabilities | ₹34.16b |
Total assets | ₹55.52b |
Recent financial health updates
Is India Glycols (NSE:INDIAGLYCO) A Risky Investment?
Jul 26India Glycols (NSE:INDIAGLYCO) Seems To Be Using A Lot Of Debt
Jun 20India Glycols (NSE:INDIAGLYCO) Has No Shortage Of Debt
Aug 23Is India Glycols (NSE:INDIAGLYCO) Using Too Much Debt?
Feb 15India Glycols (NSE:INDIAGLYCO) Use Of Debt Could Be Considered Risky
Nov 14Recent updates
India Glycols Limited (NSE:INDIAGLYCO) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough
Nov 14India Glycols' (NSE:INDIAGLYCO) Returns On Capital Not Reflecting Well On The Business
Oct 04India Glycols Limited (NSE:INDIAGLYCO) Stock Catapults 25% Though Its Price And Business Still Lag The Market
Aug 20Is India Glycols (NSE:INDIAGLYCO) A Risky Investment?
Jul 26India Glycols Limited (NSE:INDIAGLYCO) Shares Fly 28% But Investors Aren't Buying For Growth
Jul 05India Glycols' (NSE:INDIAGLYCO) Returns On Capital Not Reflecting Well On The Business
Apr 04Even With A 26% Surge, Cautious Investors Are Not Rewarding India Glycols Limited's (NSE:INDIAGLYCO) Performance Completely
Jan 05Here's What's Concerning About India Glycols' (NSE:INDIAGLYCO) Returns On Capital
Jan 02India Glycols (NSE:INDIAGLYCO) Has Announced A Dividend Of ₹7.50
Sep 02India Glycols (NSE:INDIAGLYCO) Has Announced A Dividend Of ₹7.50
Aug 19India Glycols (NSE:INDIAGLYCO) Will Want To Turn Around Its Return Trends
Sep 13India Glycols (NSE:INDIAGLYCO) Seems To Be Using A Lot Of Debt
Jun 20Here's What's Concerning About India Glycols' (NSE:INDIAGLYCO) Returns On Capital
May 12Here's Why I Think India Glycols (NSE:INDIAGLYCO) Might Deserve Your Attention Today
Mar 14India Glycols (NSE:INDIAGLYCO) Hasn't Managed To Accelerate Its Returns
Jan 25We Think That There Are Issues Underlying India Glycols' (NSE:INDIAGLYCO) Earnings
Nov 20India Glycols (NSE:INDIAGLYCO) Has No Shortage Of Debt
Aug 23India Glycols (NSE:INDIAGLYCO) Is Experiencing Growth In Returns On Capital
May 04Should India Glycols Limited (NSE:INDIAGLYCO) Be Part Of Your Dividend Portfolio?
Mar 04Is India Glycols (NSE:INDIAGLYCO) Using Too Much Debt?
Feb 15Does India Glycols (NSE:INDIAGLYCO) Have The Makings Of A Multi-Bagger?
Jan 28What Is The Ownership Structure Like For India Glycols Limited (NSE:INDIAGLYCO)?
Jan 07Can You Imagine How Jubilant India Glycols' (NSE:INDIAGLYCO) Shareholders Feel About Its 188% Share Price Gain?
Dec 20Has India Glycols Limited's (NSE:INDIAGLYCO) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Dec 02India Glycols (NSE:INDIAGLYCO) Use Of Debt Could Be Considered Risky
Nov 14Financial Position Analysis
Short Term Liabilities: INDIAGLYCO's short term assets (₹16.5B) do not cover its short term liabilities (₹18.8B).
Long Term Liabilities: INDIAGLYCO's short term assets (₹16.5B) exceed its long term liabilities (₹15.3B).
Debt to Equity History and Analysis
Debt Level: INDIAGLYCO's net debt to equity ratio (71.5%) is considered high.
Reducing Debt: INDIAGLYCO's debt to equity ratio has reduced from 97.7% to 76.4% over the past 5 years.
Debt Coverage: INDIAGLYCO's debt is not well covered by operating cash flow (17.5%).
Interest Coverage: INDIAGLYCO's interest payments on its debt are well covered by EBIT (3.6x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/18 18:59 |
End of Day Share Price | 2024/12/18 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
India Glycols Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Kameswari V. S. Chavali | FirstCall Research |